Kara Laing
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 17
- Cancer survivorship and care 9
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 4
-
- Breast Cancer Treatment Studies 8
- Co-authors
- Karen A. GelmonDeanna McLeodJohn R. MackeySunil VermaRebecca DentMelanie SealLouise ProvencherErin R. Morgan
- Journals
- Journal of Clinical Oncology (4 papers)SLEEP (2 papers)Supportive Care in Cancer (2 papers)Cancer (1 paper)Journal of Cancer Survivorship (1 paper)
- Partner nations
- CanadaUnited StatesRussia
In The Last Decade
Kara Laing
23 papers receiving 525 citations
Peers
Comparison fields: 5 of 78
- Oncology 274
- Cancer Research 138
- Geriatrics and Gerontology 34
- Family Practice 15
- Genetics 47
Countries citing papers authored by Kara Laing
This map shows the geographic impact of Kara Laing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara Laing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara Laing more than expected).
Fields of papers citing papers by Kara Laing
This network shows the impact of papers produced by Kara Laing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara Laing. The network helps show where Kara Laing may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kara Laing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 12 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2021 | 13 | |
| 10 | 2019 | 4 | |
| 11 | 2019 | 7 | |
| 12 | 2017 | 40 | |
| 13 | 2015 | 19 | |
| 14 | 2013 | 3 | |
| 15 | 2013 | 35 | |
| 16 | 2012 | 141 | |
| 17 | A population-based analysis of patients with early-stage HER2-positive breast cancer in Newfoundland and Labrador | 2012 | 6 |
| 18 | 2011 | 29 | |
| 19 | 2009 | 29 | |
| 20 | 2005 | 106 |
About Kara Laing
Kara Laing is a scholar working on Oncology, Cancer Research, Family Practice, Pulmonary and Respiratory Medicine and Economics and Econometrics, having authored 26 papers that have together received 537 indexed citations. Recurring topics across this work include Cancer survivorship and care (9 papers), Breast Cancer Treatment Studies (8 papers), Cancer-related cognitive impairment studies (7 papers), Economic and Financial Impacts of Cancer (6 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). The work is most often cited by research in Oncology (274 citations), Cancer Research (138 citations), Geriatrics and Gerontology (34 citations), Family Practice (15 citations) and Genetics (47 citations). Kara Laing has collaborated with scholars based in Canada, United States and Russia. Frequent co-authors include Karen A. Gelmon, Deanna McLeod, John R. Mackey, Sunil Verma, Rebecca Dent, Melanie Seal, Louise Provencher, Erin R. Morgan, Maureen Trudeau and Shailendra Verma. Their work appears in journals such as Journal of Clinical Oncology, SLEEP, Supportive Care in Cancer, Cancer and Journal of Cancer Survivorship.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.